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A possible function for RNA to DNA inverted transcription 
in antibody biosynthesis and irreversible differentiation 
Many authors have recently reported that inverted transcription 
from RNA to DNA was promoted by enzyme present in virions of 
oncogenic RNA viruses. It was shown that this activity was co-
ded by the viral genes; if however such an activity could be 
demonstrated as a normal attribute of higher animals, some very 
interesting possibilities are opening, that are briefly sket-
ched in what follows. 
a) Antibody biosynthesis 
The sequence determination of Bence-Jones proteins, correspon-
ding to light chains of immunoglobulins, and of heavy chains, 
have shown that both L and H chains contain invariant (C ter-
minal) and variable (N terminal) sequences. Moreover, indica-
tions exist that a single gene is coding for the constant part 
in each individual, whereas more than one gene is coding for 
the variable part of the chains (1, 2). These fundamental facts 
are not explained by the existing theories. 
In the primary immune response to antigen, a "priming" of plas-
moid cells occurs. These cells begin to synthesize antibodies 
specific to the given antigen, and become able to elicit secon-
dary response to a further stimulation by the same antigen. In 
the secondary response, a cell proliferation occurs, and a mas-
sive production of antigen takes place in the mature plasma 
cells. 
The primary response has not been obtained in vitro on lymph 
node cells cultures, however Fischman and others workers (3) 
have observed such a response when a RNA extract from macropha-
ges incubated with antigen was added to the culture. The first 
interpretation that mRNA coding for the antibody is transfer-
red to lymphoid cells and is translated there into immunoglo-
bulin chains has been challenged. One of the relevant experi-
ments showed that when macrophages of a rabbit are used to 
"prime" the lymphocytes of a rabbit of a different allotype, 
the first antibody produced was of the same allotype as the 
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macrophages, but after some time the allotype of the antibody 
reverted to that of the recipient rabbit (4). 
Apart from this experiment, it is clear that transfer of mRNA 
cannot per se solve the problem of the antibody synthesis; it 
is still not clear how the mRNA, however stabilized, can be trans-
mitted to many daughter cells deriving from the original "primed" 
cell in secondary reaction, unless we admit that the mRNA is re-
plicated like DNA during cell duplication. The same difficulty 
arise also if we suppose that the antigen itself, or a fragment 
of it including the determinant groups is instrumental in the bio-
synthesis of the antibody in any single plasma cell. It is likely 
that in secondary reaction there may be more antibody producing 
cells than there are antigen molecules If the inverted trans-
cription is postulated, it seems that the following hypothetical 
scheme offers a break-through in the way to the solution of anti-
body synthesis problem. 
The genes corresponding to the constant parts and many versions 
of the variable parts of both L and H chains exist separately. 
In the macrophages both are transcribed and at least the mRNA 
corresponding to the variable part is translated. These mRNAs 
are not destroyed but are retained linked to the peptide chains 
coded by them, in a molecular complex in some specific organel-
les. An antigen molecule reaching the macrophage selects the va-
riable peptide chains of both the L and H type, with the same 
chemical specificity governing antigen-antibody reaction. This 
interaction triggers in the complex a mechanism (of course an 
enzimatic system must be postulated) that causes the assembling 
of the mRNA coding for the variable parts with the mRNA coding 
for the constant part of the respective L and H chains. This 
requires simply the linkage of the two (or more, see further) 
mRNAs. The mRNA for the complete L and H chains are now ready. 
They are released from the organelle and trasnferred to the reci-
pient plasmoid cell where they are transcribed to DNA and inser-
ted like an episome in the genome of the recipient cell. The in-
sertion in the right place is assured by the fact that the se-
quence corresponding to the constant part is matching with the 
base conjugated sequence in the DNA of the recipient cell, and 
may easily replace the original strand in the double helix, 
while the variable part results in an extra addition, which may 
be easily complemented in the template strand by the repair me-
chanisms of the cell. The plasmoid cell is now "primed" and ready 
to synthesize antibody in the normal transcription-translation 
way, as well as to transmit the relevant information to all its 
progeny. We shall also admit that the new insertion affects the 
genome in the sense that proliferation is promoted; this will 
occur (regulation via repression induction mechanism in the first 
guess) when the primed cell is further stimulated by the same 
antigen, resulting in secondary response. 
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It must be noted that reversion after some time to the recipient 
cell allotype in the experiment quoted is readily understood in 
this scheme: the allotype marker is in the constant part; the 
DNA transcribed from mRNA correspond to the transcribed strand 
of the double helix: a defect of complementarity to the corres-
ponding template strand will be present and after some time will 
eventually be eliminated by the repair mechanisms of the cell. 
It is clear that the scheme postulated offers a direct explana-
tion of the existence of constant and variable parts in immuno-
globulin chains, as well as of the fact that constant parts are 
coded for by a single gene, whereas the opposite occurs for va-
riable parts. The scheme offers also a straight-forward explana-
tion of the remarkable phenomenon of allelic exclusion (1), i.e. 
that each single cell of heterozygous subjects is producing anti-
body of either one allotype or the other, but not both. Of course 
"priming" in our scheme, will occur on only one of the homologous 
chromosomes, and the effect follows immediately. As for what con-
cerns translocation hypothesis in their various form, they offer 
an explanation for some of the points discussed, however they do 
not justify the role of transferred RNA in priming; moreover, 
they face the difficulty of explaining how the DNA sequences cor-
responding to the variable parts of antibody chains may find the 
right location adiacent to the proper common sequence. All this 
difficulties are overcome in our scheme, in which the selection 
by the antibody, the "priming" of the stem cells, and the relo-
cation of variable sequences near the constant one are all the 
result of the same integrated process. Additional flexibility in 
the scheme is given by the fact that we are not bound to main-
tain that the variable parts are selected as a whole by the anti-
gen. The mRNA assembling process may concern more than two poly-
nucleotides building blocks, thereby reducing further the amount 
of genetic information necessary to explain the great number of 
possible antibodies. 
This may lessen the strenght of the arguments in favour of the 
somatic random mutability as postulated by clonal selection 
theory which is rather hard to accept for many people. 
b) Irreversible differentiation 
In immune response a very peculiar type of cell differentiation 
occurs. 
Let us consider the general problem of irreversible differentia-
tion. It has been shown in many experiments that in higher ani-
mals some fundamental steps in differentiation occur, after 
which the cells, and the clones taking birth from them, are irre-
versibly committed to a definite path of differentiation. This 
change must affect the genome itself, as various environmental 
conditions and even transplantation of nuclei do not invert 
this differentiation. It is generally accepted that a large part 
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of genetic information is silent in cells, and different spe-
cific genes may be activated in the differentiated cells. How-
ever induction-repression mechanism alone cannot explain a real 
irreversible differentiation transferable to daughter cells. 
Even the hvstone structure and DNA tridimensional configuration 
is not likely to cause a true hereditary modification, since 
both are not expected to survive the dramatic changes in configu-
ration during mitosis, unless one admits that the replication 
process is not limited to DNA itself, but includes replication 
of many other molecules. We are thus lead to the assumption that 
irreversible differentiation must affect the DNA sequence itself. 
On the other hand, it is evident that the fundamental differen-
tiation steps must be programmed in some way in the genotype, 
that is in the DNA of the fertilized egg. We are thus faced with 
an apparent dilemma. 
Some hypothetical mechanism are available for DNA modification 
based essentially on gene duplication, and subsequent disloca-
tion and recombination. However the problem is to find a mecha-
nism that can produce a specific change in response to a spe-
cific signal. A way to solution may be found in a generalization 
of the scheme proposed for primary immune response. Different DNA 
sequences may be transcribed, and the corresponding mRNA trans-
lated and retained linked to their daughter peptides in a macro-
molecular complex. A specific protein produced in the same orga-
nism, may react with one of the peptides and trigger the fusion 
of mRNAs. The new mRNA thus assembled may be retranscribed back 
to DNA and reinserted in a specific location in the same or in 
a nearby cell. 
Such a mechanism will lead to a preprogrammed reshuffling of 
the genetic information included in the DNA of the genotype, 
according to specific signals, thus offering a solution to 
the described dilemma. 
c) A new approach to cancer problem? 
Myeloma tumor cells which produce Bence-Jones proteins may be 
regarded as immunocompetent irregularly "primed" cells in which 
some control mechanism is lost, so that uncontrolled prolifera-
tion and constitutive synthesis of immunoglobulin chains deve-
lops. It is clear that "priming" (that is, according to our 
hypothesis, insertion of a new fragment of DNA in a specific 
position) must affect the genome in the sense of stimulating, 
under proper conditions, the replication process, as this is 
the condition for secondary response. In the normal case, the 
primary response (i.e. the initial differentiation step) leads 
finally in successive differentiation steps, to plasma cells 
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which are no more able to proliferate. All this implies specific 
control mechanism having relation to the extra DNA sequence added. 
This control may fail in case of myeloma tumor cells. The same 
situation may apply to the general differentiation scheme: The 
initial "priming" change is followed by active proliferation and 
progressive differentiation of a clone, that must be stopped by 
control mechanism at the right, preprogrammed point. 
An irregular "priming" process may lead to the loss of the essen-
tial control mechanism because of the specific character of the 
added DNA sequence and thereby to cancer. This situation parallels 
very well, in our hypothesis, what is likely to occur in RNA vi-
ruses induced tumours. We may admit that such viruses act in the 
same way as the "priming" mRNA in our hypothesis, and loss of pro-
liferation control results. 
We are thus lead to hypothesize the following evolutionistic path-
way: A mechanism of irreversible differentiation has been invol-
ved in higher animals, based on mRNA reassembling and reversed 
transcription followed by episomatic reinsertion of DNA, stimula-
ting controlled proliferation. A specialization of this mechanism 
has led to immunitary response. Cancer may be the consequence of 
the misfunctioning of these mechanisms. 
The author is well aware that all the matter is entirely hypothe-
tical. It seems however that the hypothesis is not unjustified, 
and may stimulate theoretical discussion and experimental inves-
tigation. 
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Final Note 
The ideas expressed in this work were conceived in 1969. 
The redaction in the present form is of february 1 971 , stimula­
ted by the publication (Nature, June 1970) of Temin and Balti­
more results on the existence of RNA directed DNA polymerase 
in virions. 
Such "reverse transcriptase" enzyme was postulated by the pre­
sent theory. Now it has been shown that reverse transcription 
activity exist also in non infected cells, especially in em­
bryons, as it is demanded by the theory. In Ternin»s laboratory 
a polynucleotide ligase has been isolated from Rous virions. 
Temin himself suggests that its function could be that of in­
serting the DNA resulting from reverse transcription of viral 
RNA into the host cell genome. All these results bring a strong 
support the theory; to complete the picture from the point of 
view of enzymatic activity, a RNA ligase must be found which 
should weld together the mRNA's in specific situations. 
A quest for such an enzyme will eventually begin in Ispra in the 
next months. 
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